Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Current Taxes (2020 - 2026)

Adagene (ADAG) posted quarterly Current Taxes of $410.2 billion for Q4 2025, up 7691.04% year-over-year from $5.3 billion in Q4 2024, and up 9953846053.85% quarter-over-quarter from $4121.0 in Q2 2025.

Analysis

Adagene (ADAG) Current Taxes (2020 - 2026) Analysis & Trends

Adagene (ADAG) has reported Current Taxes for 6 consecutive years, with $410.2 billion the latest figure, recorded in Q4 2025.

  • In Q4 2025, Current Taxes rose 7691.04% year-over-year to $410.2 billion; the TTM figure through Dec 2025 stood at $410.2 billion (up 7691.04% YoY), while the FY2025 annual figure was $410.2 billion, up 7691.04% from the prior year.
  • Current Taxes climbed to $410.2 billion in Q4 2025 per ADAG's latest filing, from $4121.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $2256.6 billion in Q2 2022 and bottomed at $4121.0 in Q2 2025.
  • Historically, Current Taxes has averaged $513.3 billion across 5 years, with a median of $5.3 billion in 2024.
  • Annual changes were most pronounced in 2023 — Current Taxes jumped 15151215.47% — and 2024, when it plunged 100.0%.
  • Adagene's Current Taxes stood at $1.7 million in 2021, then slumped by 78.94% to $349039.0 in 2022, then surged by 15151215.47% to $52.9 billion in 2023, then tumbled by 90.04% to $5.3 billion in 2024, then soared by 7691.04% to $410.2 billion in 2025.
  • Business Quant data shows ADAG's Current Taxes at $410.2 billion in Q4 2025, $4121.0 in Q2 2025, and $5.3 billion in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 49.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 76.32 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Adagene 211.24 Mn 211.24 Mn - 583,199.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 583,199.00
Dec 31, 2025 410,198.00
Jun 30, 2025 4,121.00
Dec 31, 2024 5,265.00
Jun 30, 2024 38,382.00
Dec 31, 2023 52,884.00
Jun 30, 2023 1.90 Mn
Dec 31, 2022 349,039.00
Jun 30, 2022 2.26 Mn
Dec 31, 2021 1.66 Mn
Dec 31, 2020 63,919.00